12 June 2020 : Database Analysis
Identification of an Immune Score-Based Gene Panel with Prognostic Power for Oral Squamous Cell Carcinoma
Su-Ning Huang1ACEF, Guo-Sheng Li1BCEF, Xian-Guo Zhou2AE, Xiao-Yi Chen1BCE, Yu-Xuan Yao1BCE, Xiao-Guohui Zhang1BCE, Yao Liang1BCE, Ming-Xuan Li1BCE, Gang Chen3ACDEFG, Zhi-Guang Huang3AE, Yi-Wu Dang3AE, Jing Li4AE, Ping Li5ACDE, Xiao-Zhun Tang6ACDEFG*, Min-Hua Rong2ABCEFDOI: 10.12659/MSM.922854
Med Sci Monit 2020; 26:e922854
Abstract
BACKGROUND: Oral squamous cell carcinoma (OSCC) is the sixth most prevalent cancer worldwide, with low 5-year survival rate. To identify novel prognostic markers for OSCC and determine the immune and stromal landscape of OSCC, a risk signature for OSCC patients was constructed in this study.
MATERIAL AND METHODS: Immune and stromal scores for OSCC samples from the Genomic Data Commons Data Portal were computed to delineate the tumor microenvironment landscape of oral cancer based on the Estimation of STromal and Immune cells in MAlignant Tumours using Expression data algorithm. An immune score-based risk signature was constructed by combining random forest and support vector machine methods. Correlation analysis of risk signature gene expression and immune cell infiltration was conducted, and the distinguishing power of individual signature genes was evaluated by analyzing receiver operating characteristics (ROC) curves. Differentially enriched pathways between high and low risk groups were investigated via gene set variation analysis. ROC curves were plotted for signature genes to examine their ability to distinguish the recurrence and survival status of OSCC patients from GSE84846.
RESULTS: An immune score-related risk signature composed of ARMH1, F2RL2, AC004687.1, COL6A5, AC008750.1, RAB19, CRLF2, GRIP2, and FAM162B performed well in the prognostic stratification of OSCC patients and could effectively distinguish their survival status. Lists of pathways, including cytokine–cytokine receptor interaction and cell adhesion molecules displayed remarkable differential enrichment between high and low risk OSCC patients.
CONCLUSIONS: An immune score-based risk signature constructed presently may be useful to decide appropriate treatment options for individual OSCC patients.
Keywords: Corneal Stroma, Immunity, Cellular, Microarray Analysis, Mouth Neoplasms, Sequence Analysis, RNA, Cytokines, Databases, Genetic, Immune System, Lymphocytes, Tumor-Infiltrating, Multivariate Analysis, Proportional Hazards Models, Protein Interaction Maps, RNA, Messenger, RNA-Seq, ROC Curve, Receptors, Cytokine, Risk Assessment, Squamous Cell Carcinoma of Head and Neck, support vector machine, tumor microenvironment
Editorial
01 January 2025 : Editorial
Editorial: The Human Cell Atlas. What Is It and Where Could It Take Us?DOI: 10.12659/MSM.947707
Med Sci Monit 2025; 31:e947707
In Press
Animal Research
Role of the Dorsal Cortex of the Inferior Colliculus in the Precedence EffectMed Sci Monit In Press; DOI: 10.12659/MSM.945605
Laboratory Research
Comparative Evaluation of the Dimensional Accuracy of Silicone-Based Putty Reline Impressions with Differen...Med Sci Monit In Press; DOI: 10.12659/MSM.946537
Clinical Research
Ankle-Brachial Index as a Predictor of Acute Ischemic Cerebrovascular Event After Central Retinal Artery Oc...Med Sci Monit In Press; DOI: 10.12659/MSM.945937
Review article
COL3A1 Gene Polymorphism and Its Impact on Female Pelvic Organ ProlapseMed Sci Monit In Press; DOI: 10.12659/MSM.946367
Most Viewed Current Articles
17 Jan 2024 : Review article 6,962,174
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 699,683
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 22,873
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 17,628
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912